UBS Group AG - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 35 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$2,000
-50.0%
10,000
-17.8%
0.00%
Q4 2017$4,000
-77.8%
12,170
-64.2%
0.00%
Q3 2017$18,000
+5.9%
33,995
+15.3%
0.00%
Q2 2017$17,000
+240.0%
29,484
+492.6%
0.00%
Q2 2016$5,000
-50.0%
4,975
-19.9%
0.00%
Q4 2015$10,000
+400.0%
6,211
+539.6%
0.00%
Q3 2015$2,000971
+48450.0%
0.00%
Q2 2015$0
-100.0%
2
-99.6%
0.00%
Q1 2015$2,0004950.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q1 2016
NameSharesValueWeighting ↓
EAM Investors, LLC 670,593$3,401,0000.45%
Prospera Financial Services Inc 184,100$236,0000.05%
HighTower Advisors, LLC 1,047,731$1,257,0000.01%
TWO SIGMA SECURITIES, LLC 15,142$18,0000.01%
TEACHERS ADVISORS, LLC 298,781$1,820,0000.00%
TIAA CREF INVESTMENT MANAGEMENT LLC 724,455$4,412,0000.00%
Virtu KCG Holdings LLC 90,490$109,0000.00%
FIRST FOUNDATION ADVISORS 10,000$12,0000.00%
Acrospire Investment Management LLC 2,300$3,0000.00%
Balentine LLC 55$00.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders